Lindbrook Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Lindbrook Capital's AMGN Position: Q1 2025 in Review
Lindbrook Capital increased its Amgen (AMGN) stake by 20% in Q1 2025, buying an estimated $136K and bringing the position to 2,710 shares worth $844K. The position accounts for 0.08% of the portfolio, ranked #150.
Lindbrook Capital first reported a position in AMGN in Q4 2018 and has held it in 26 quarters since. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Lindbrook Capital held 2,710 shares of Amgen worth $844K as of Q1 2025.
- Lindbrook Capital bought 461 Amgen shares in Q1 2025, an estimated $136K.
- Amgen made up 0.08% of Lindbrook Capital's portfolio in Q1 2025, its #150 holding.
- Lindbrook Capital first reported a position in Amgen in Q4 2018 and has held it in 26 quarters since.
- 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.